Abstract
Amniotic band syndrome is a group of sporadic congenital anomalies that involve the limbs, craniofacial regions and trunk, ranging from simple digital band constriction to complex craniofacial and central nervous system abnormalities. Placento-cranial adhesions in amniotic band syndrome are extremely rare, and severe conditions are associated with high morbidity and mortality rates. In this study, we pooled placento-cranial adhesion case reports that were published in the medical literature and added an unpublished case from our institution. The purpose of this article was to review and discuss the clinical features and outcomes of placento-cranial adhesions in amniotic band syndrome.
References
1.
Seeds JW, Cefalo RC, Herbert WN: Amniotic band syndrome. Am J Obstet Gynecol 1982;144:243-248.
2.
Merrimen JL, McNeely PD, Bendor-Samuel RL, Schmidt MH, Fraser RB: Congenital placental-cerebral adhesion: an unusual case of amniotic band sequence. Case report. Neurosurgery 2006;104:352-355.
3.
Venkat Rau JB: Abnormal foetal attachment of placenta. Indian Pediatr 1976;13:55-56.
4.
Purohit M, Purohit NN, Garg OP, Gupta CB: Cranium bifidum with abnormal foetal attachment of placenta. Indian Pediatr 1977;14:665-666.
5.
Chandran S, Lim MK, Yu VY: Fetal acalvaria with amniotic band syndrome. Arch Dis Child Fetal Neonatal Ed 2000;82:11-13.
6.
Ghritlaharey RK, Kushwaha AS, Chanchlani R, Nanda M: Placento-cranial adhesion: a report of two cases. J Indian Assoc Pediatr Surg 2007;12:102-103.
7.
Woyton J: Encephalocele attached to the placenta. Am J Obstet Gynecol 1961;81:1028-1032.
8.
Liban E, Abramovici A: Fetal membrane adhesions and congenital malformations; in Klingerg MA, et al (eds): Drugs and Fetal Development. New York, Plenum Press, 1972, pp 337-350.
9.
D'Souza J, Indrajit IK, Menon S: Limb body wall complex. Med J Armed Forces India (MJAFI) 2004;60:77-80.
10.
Streeter GL: Focal deficiency in fetal tissues and their relation to intrauterine amputation. Contrib Embryol Carnegie Inst 1930;22:1-46.
11.
Torpin R: Amniochorionic mesoblastic fibrous strings and amnionic bands: associated constricting fetal malformations or fetal death. Am J Obstet Gynecol 1965;91:65-75.
12.
Russo R, D'Armiento M, Angrisani P, Vecchione R: Limb body wall complex: a critical review and a nosological proposal. Am J Med Genet 1993;47:893-900.
13.
Lee SH, Lee MJ, Kim MJ, Son GH, Namgung R: Fetal MR imaging of constriction band syndrome involving the skull and brain. J Comput Assist Tomogr 2011;35:685-687.
14.
Chen CP, Chang TY, Lin YH, Wang W: Prenatal sonographic diagnosis of acrania associated with amniotic bands. J Clin Ultrasound 2004;32:256-260.
15.
Cincore V, Ninios AP, Pavlik J, Hsu CD: Prenatal diagnosis of acrania associated with amniotic band syndrome. Obstet Gynecol 2003;102:1176-1178.
16.
He P, Yang Y, Li DZ: Acrania associated with amniotic bands in a fetus. J Obstet Gynaecol 2012;32:397-398.
17.
Dies KA, Bodell A, Hisama FM, Guo CY, Barry B, Chang BS, Barkovich AJ, Walsh CA: Schizencephaly: association with young maternal age, alcohol use, and lack of prenatal care. J Child Neurol 2013;28:198-203.
18.
Curry CJ, Lammer EJ, Nelson V, Shaw GM: Schizencephaly: heterogeneous etiologies in a population of 4 million California births. Am J Med Genet A 2005;137:181-189.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.